In accordance with Section 7062(a) of the SUPPORT Act, in 2019 HHS published the first Status Report on Protecting Our Infants Act Implementation Plan, which included activities through August 2018 on the identification, prevention and treatment of Neonatal Abstinence Syndrome (NAS) and opioid use disorder in pregnant women. The current, updated Status Report provides an overview of HHS-wide programs implemented from September 2018 through December 2019. The report features an overview of HHS-funded activities to address gaps in data and surveillance, research and evaluation, programs and services for prenatal opioid exposure and NAS, provider training and public awareness efforts. Appendix A includes a detailed table of HHS activities on prevention, identification and treatment of prenatal opioid exposures and NAS. The information in the table is organized by agency and includes references to the relevant POIA recommendations to show the implemented activities under the POIA strategy.
For additional information about this subject, you can visit the HHS/ASPE/Office of Behavioral Health, Disability, and Aging Policy home page https://aspe.hhs.gov/about/offices/bhdap or contact the ASPE Project Officer at HHS/ASPE/BHDAP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue, S.W., Washington, D.C. 20201, Kristina.West@hhs.gov.
- Status Report on Protecting Our Infants Act Implementation Plan: 2019 (September 2021)
- Status Report on Protecting Our Infants Act Implementation Plan (January 2019)